Mosaic Immunoengineering Stock Today
| CPMV Stock | USD 0.60 0.01 1.69% |
Performance6 of 100
| Odds Of DistressOver 76
|
Mosaic Immunoengineerin is selling for under 0.6 as of the 3rd of May 2024; that is 1.69 percent increase since the beginning of the trading day. The stock's lowest day price was 0.6. Mosaic Immunoengineerin has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Mosaic Immunoengineering are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of April 2024 and ending today, the 3rd of May 2024. Click here to learn more.
Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. The company was founded in 2020 and is based in Novato, California. The company has 7.24 M outstanding shares. More on Mosaic Immunoengineering
Moving against Mosaic OTC Stock
| 0.48 | MRNA | Moderna Earnings Call This Week | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Mosaic OTC Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Mosaic Immunoengineerin's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Mosaic Immunoengineerin or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Mosaic Immunoengineering [CPMV] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.01 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mosaic Immunoengineerin's market, we take the total number of its shares issued and multiply it by Mosaic Immunoengineerin's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Mosaic Immunoengineering conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 7.24 M outstanding shares.
Mosaic Immunoengineering currently holds about 205.99 K in cash with (679.24 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03.
Check Mosaic Immunoengineerin Probability Of Bankruptcy
Ownership AllocationMosaic Immunoengineering secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 88.73 % of Mosaic Immunoengineering outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event.
Check Mosaic Ownership Details
Mosaic Stock Price Odds Analysis
Depending on a normal probability distribution, the odds of Mosaic Immunoengineerin jumping above the current price in 90 days from now is about 15.87%. The Mosaic Immunoengineering probability density function shows the probability of Mosaic Immunoengineerin otc stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Mosaic Immunoengineering has a beta of -6.63 suggesting as returns on its benchmark rise, returns on holding Mosaic Immunoengineering are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Mosaic Immunoengineerin is expected to outperform its benchmark. In addition to that, mosaic Immunoengineering has an alpha of 2.1088, implying that it can generate a 2.11 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Mosaic Immunoengineerin to move above the current price in 90 days from now is about 15.87 (This Mosaic Immunoengineering probability density function shows the probability of Mosaic OTC Stock to fall within a particular range of prices over 90 days) .
Mosaic Immunoengineering Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Mosaic Immunoengineerin market risk premium is the additional return an investor will receive from holding Mosaic Immunoengineerin long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Mosaic Immunoengineerin. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Mosaic Immunoengineerin's alpha and beta are two of the key measurements used to evaluate Mosaic Immunoengineerin's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 8.92 | |||
| Semi Deviation | 10.79 | |||
| Standard Deviation | 20.11 | |||
| Variance | 404.59 |
Mosaic Stock Against Markets
Picking the right benchmark for Mosaic Immunoengineerin otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Mosaic Immunoengineerin otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Mosaic Immunoengineerin is critical whether you are bullish or bearish towards Mosaic Immunoengineering at a given time. Please also check how Mosaic Immunoengineerin's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Mosaic Immunoengineerin without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
| All Next | Launch Module |
Mosaic Immunoengineerin Corporate Management
Elected by the shareholders, the Mosaic Immunoengineerin's board of directors comprises two types of representatives: Mosaic Immunoengineerin inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mosaic. The board's role is to monitor Mosaic Immunoengineerin's management team and ensure that shareholders' interests are well served. Mosaic Immunoengineerin's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mosaic Immunoengineerin's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jay Carlson | Sr Relations | Profile | |
| Steven King | Pres Chairman | Profile | |
| Cyril Empig | Head Devel | Profile | |
| Marvin MD | Head ImmunoOncology | Profile | |
| Nicole Steinmetz | Acting Director | Profile | |
| Paul CPA | CFO, VP | Profile | |
| Joseph MPH | Head Operations | Profile |
How to buy Mosaic OTC Stock?
Before investing in Mosaic Immunoengineerin, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Mosaic Immunoengineerin. To buy Mosaic Immunoengineerin stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Mosaic Immunoengineerin. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Mosaic Immunoengineerin stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Mosaic Immunoengineering stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Mosaic Immunoengineering stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Mosaic Immunoengineering, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Mosaic Immunoengineering?
The danger of trading Mosaic Immunoengineering is mainly related to its market volatility and OTC Stock specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Mosaic Immunoengineerin is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Mosaic Immunoengineerin. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Mosaic Immunoengineering is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Mosaic Immunoengineering. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Mosaic OTC Stock analysis
When running Mosaic Immunoengineerin's price analysis, check to measure Mosaic Immunoengineerin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mosaic Immunoengineerin is operating at the current time. Most of Mosaic Immunoengineerin's value examination focuses on studying past and present price action to predict the probability of Mosaic Immunoengineerin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mosaic Immunoengineerin's price. Additionally, you may evaluate how the addition of Mosaic Immunoengineerin to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |